National News
NAFDAC halts Artemether/Lumefantrine registration
The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
News1 day agoNUJ FCT Council applauds Governors’ support for reserved seats for women bill
-
News2 days agoRotary Club of Abuja Maitama leads Polio immunization drive in Duste Alhaji
-
News2 days agoCourt adjourns Nnamdi Kanu’s trial as IPOB Leader fails to begin defence
-
News2 days agoCourt grants bail to Sowore, Nnamdi Kanu’s Lawyer, Other #FreeNnamdiKanuNow protesters
-
National News1 day agoBREAKING: Major Military overhaul as Tinubu dismisses top Service Chiefs, name replacements
-
News12 hours agoAIBEN unveils another multi billion Naira Bourdillon hotel to boost Abuja’s hospitality sector (Video)
-
National News1 day agoTinubu names Gen. W. Shaibu as new Chief of Army Staff
-
News1 day agoBREAKING: FATF removes Nigeria from watchlist on Money laundering, terror financing



